» Articles » PMID: 20686033

Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture

Overview
Journal J Virol
Date 2010 Aug 6
PMID 20686033
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the biochemical and ultrastructural properties of hepatitis C virus (HCV) particles produced in cell culture. Negative-stain electron microscopy revealed that the particles were spherical (∼40- to 75-nm diameter) and pleomorphic and that some of them contain HCV E2 protein and apolipoprotein E on their surfaces. Electron cryomicroscopy revealed two major particle populations of ∼60 and ∼45 nm in diameter. The ∼60-nm particles were characterized by a membrane bilayer (presumably an envelope) that is spatially separated from an internal structure (presumably a capsid), and they were enriched in fractions that displayed a high infectivity-to-HCV RNA ratio. The ∼45-nm particles lacked a membrane bilayer and displayed a higher buoyant density and a lower infectivity-to-HCV RNA ratio. We also observed a minor population of very-low-density, >100-nm-diameter vesicular particles that resemble exosomes. This study provides low-resolution ultrastructural information of particle populations displaying differential biophysical properties and specific infectivity. Correlative analysis of the abundance of the different particle populations with infectivity, HCV RNA, and viral antigens suggests that infectious particles are likely to be present in the large ∼60-nm HCV particle populations displaying a visible bilayer. Our study constitutes an initial approach toward understanding the structural characteristics of infectious HCV particles.

Citing Articles

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.

Ali A, Azouz R, Hussein N, El-Shenawy R, Helmy N, El-Abd Y BMC Biotechnol. 2025; 25(1):8.

PMID: 39827115 PMC: 11742997. DOI: 10.1186/s12896-024-00935-5.


Carcinogenic mechanisms of virus-associated lymphoma.

Zhang Y, Guo W, Zhan Z, Bai O Front Immunol. 2024; 15:1361009.

PMID: 38482011 PMC: 10932979. DOI: 10.3389/fimmu.2024.1361009.


A state-of-the-art review of the recent advances in exosome isolation and detection methods in viral infection.

Gorgzadeh A, Nazari A, Ali Ehsan Ismaeel A, Safarzadeh D, Hassan J, Mohammadzadehsaliani S Virol J. 2024; 21(1):34.

PMID: 38291452 PMC: 10829349. DOI: 10.1186/s12985-024-02301-5.


Prospects for developing an Hepatitis C virus E1E2-based nanoparticle vaccine.

Toth E, Andrianov A, Fuerst T Rev Med Virol. 2023; 33(5):e2474.

PMID: 37565536 PMC: 10626635. DOI: 10.1002/rmv.2474.


Hepatitis C Virus (HCV)-Ribonucleic Acid (RNA) As a Biomarker for Lymphoid Malignancy with HCV Infection.

Tsutsumi Y, Ito S, Shiratori S, Teshima T Cancers (Basel). 2023; 15(10).

PMID: 37345190 PMC: 10216073. DOI: 10.3390/cancers15102852.


References
1.
Choukhi A, Ung S, Wychowski C, Dubuisson J . Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J Virol. 1998; 72(5):3851-8. PMC: 109609. DOI: 10.1128/JVI.72.5.3851-3858.1998. View

2.
Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland J, Sodoyer M . Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol. 2002; 76(14):6919-28. PMC: 136313. DOI: 10.1128/jvi.76.14.6919-6928.2002. View

3.
Zhong J, Gastaminza P, Chung J, Stamataki Z, Isogawa M, Cheng G . Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J Virol. 2006; 80(22):11082-93. PMC: 1642175. DOI: 10.1128/JVI.01307-06. View

4.
Baumert T, Vergalla J, Satoi J, Thomson M, Lechmann M, Herion D . Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology. 1999; 117(6):1397-407. DOI: 10.1016/s0016-5085(99)70290-8. View

5.
Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A . Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol. 2008; 82(16):7964-76. PMC: 2519576. DOI: 10.1128/JVI.00826-08. View